Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1361 Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.